Modulating Fatty Acid Enzymes to Boost Isoprenoid Yields
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing isoprenoids and isoprenoid precursors face challenges such as low yields, impurities, and high costs due to the complexity and inefficiency of chemical synthesis, as well as the limitations of extracting these compounds from natural sources, which motivates the need for alternative biological production methods.
Innovation Solution
Modulating the activity of fatty acid biosynthetic pathway enzymes in host cells and culturing them in media with specific fatty acids or increased osmolarity to enhance the production of isoprenoids or their precursors, utilizing genetically modified microorganisms like E. coli to convert acetyl-CoA into isopentenyl pyrophosphate through the mevalonate pathway.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis routes are used to produce isoprenoids, then production scalability is improved, but manufacturing complexity and cost increase significantly
Solution Approach 1:
The patent replaces complex chemical synthesis mechanisms with biological enzymatic mechanisms. Genetically modified microorganisms use enzymatic pathways (mevalonate pathway and fatty acid biosynthetic pathway) to convert simple substrates like acetyl-CoA into isoprenoids, eliminating the need for complex multi-step chemical synthesis procedures while maintaining scalability
Solution Approach 2:
The patent changes the fundamental production parameter from chemical reactions to biological metabolic pathways. By modifying microbial genomes to overexpress specific enzymes (e.g., HMGR, mevalonate kinase), the system transforms metabolic flux parameters to redirect carbon flow toward isoprenoid production, achieving scalability through biological amplification rather than chemical complexity
2Ease of manufacture
If extraction from natural sources is used, then production simplicity is improved, but yield and purity deteriorate
Solution Approach 1:
The patent enables microorganisms to self-produce isoprenoids through engineered metabolic pathways rather than requiring external extraction. The genetically modified cells autonomously convert substrates like acetyl-CoA into isoprenoid products through overexpressed enzymatic pathways, transforming the process from passive extraction to active self-synthesis with improved yields
Solution Approach 2:
The patent performs preliminary genetic engineering to establish productive metabolic pathways before production begins. By pre-modifying the microbial genome to overexpress key enzymes (HMGR, mevalonate kinase, phosphomevalonate kinase), the system is prepared to efficiently convert substrates into isoprenoids, avoiding the need for complex extraction processes while achieving higher yields
3Productivity
If HMG-CoA accumulation is allowed, then fatty acid biosynthesis is improved, but toxicity increases
Solution Approach 1:
The patent extracts or removes HMG-CoA from the cellular environment by directing it into alternative metabolic pathways. The engineered system channels HMG-CoA through the mevalonate pathway toward isoprenoid production, preventing its toxic accumulation while maintaining fatty acid biosynthesis through coordinated expression of fatty acid biosynthetic enzymes
Solution Approach 2:
The patent introduces the mevalonate pathway as an intermediary channel between HMG-CoA production and toxic accumulation. By overexpressing mevalonate kinase and phosphomevalonate kinase, the system creates a metabolic bridge that converts HMG-CoA into mevalonate and subsequently into isoprenoid products, preventing toxicity while maintaining productivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the production levels of isoprenoids or their precursors, reducing toxicity from HMG-CoA accumulation and improving the scalability and efficiency of isoprenoid production, potentially reaching yields up to several fold higher than traditional methods.
Implementation Method 1
genetically modified host cells that convert acetyl-CoA to isopentenyl pyrophosphate through the mevalonate pathway
Implementation Method 2
modulating the level of activity of a fatty acid biosynthetic pathway enzyme in the host cell
Implementation Method 3
culturing the host cell in a culture medium having increased osmolarity
Data Source
AI summary
The present invention provides methods of increasing production of an isoprenoid or an isoprenoid precursor in a host cell, the methods generally involving modulating the level of activity of a fatty acid biosynthetic pathway enzyme in the host cell and/or culturing the host cell in a culture medium comprising a fatty acid or a compound that can be metabolized in a cell or broken down in the medium to yield a fatty acid and/or culturing the host cell in a culture medium having increased osmolarity.